Gill Jasmeet K, Maskarinec Gertraud, Pagano Ian, Kolonel Laurence N
Cancer Research Center of Hawaii, Honolulu, Hawaii, USA.
Breast Cancer Res. 2006;8(3):R30. doi: 10.1186/bcr1507. Epub 2006 Jun 23.
It is well established that women with high mammographic density are at greater risk for breast cancer than are women with low breast density. However, little research has been done on mammographic density and ductal carcinoma in situ (DCIS) of the breast, which is thought to be a precursor lesion to some invasive breast cancers.
We conducted a nested case-control study within the Multiethnic Cohort, and compared the mammographic densities of 482 patients with invasive breast cancer and 119 with breast DCIS cases versus those of 667 cancer-free control subjects. A reader blinded to disease status performed computer-assisted density assessment. For women with more than one mammogram, mean density values were computed. Polytomous logistic regression models were used to compute adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for two measurements of mammographic density: percentage density and dense area.
Mammographic density was associated with invasive breast cancer and breast DCIS. For the highest category of percentage breast density (> or = 50%) as compared with the lowest (< 10%), the OR was 3.58 (95% CI 2.26-5.66) for invasive breast cancer and 2.86 (1.38-5.94) for breast DCIS. Similarly, for the highest category of dense area (> or = 45 cm2) as compared with the lowest (< 15 cm2), the OR was 2.92 (95% CI 2.01-4.25) for invasive breast cancer and 2.59 (1.39-4.82) for breast DCIS. Trend tests were significant for invasive breast cancer (P for trend < 0.0001) and breast DCIS (P for trend < 0.001) for both percentage density and dense area.
The similar strength of association for mammographic density with breast DCIS and invasive breast cancer supports the hypothesis that both diseases may have a common etiology.
乳腺钼靶密度高的女性患乳腺癌的风险明显高于乳腺密度低的女性,这一点已得到充分证实。然而,关于乳腺钼靶密度与乳腺导管原位癌(DCIS)的研究较少,而DCIS被认为是某些浸润性乳腺癌的前驱病变。
我们在多民族队列中开展了一项巢式病例对照研究,比较了482例浸润性乳腺癌患者、119例乳腺DCIS患者与667例无癌对照者的乳腺钼靶密度。一名对疾病状态不知情的阅片者进行了计算机辅助密度评估。对于有多次钼靶检查的女性,计算平均密度值。采用多分类逻辑回归模型计算乳腺钼靶密度两项测量指标(密度百分比和致密面积)的校正比值比(OR)和95%置信区间(CI)。
乳腺钼靶密度与浸润性乳腺癌和乳腺DCIS均相关。与最低密度类别(<10%)相比,最高密度类别(≥50%)的浸润性乳腺癌OR为3.58(95%CI 2.26 - 5.66),乳腺DCIS的OR为2.86(1.38 - 5.94)。同样,与最低致密面积类别(<15 cm²)相比,最高致密面积类别(≥45 cm²)的浸润性乳腺癌OR为2.92(95%CI 2.01 - 4.25),乳腺DCIS的OR为2.59(1.39 - 4.82)。对于密度百分比和致密面积,浸润性乳腺癌(趋势P<0.0001)和乳腺DCIS(趋势P<0.001)的趋势检验均具有显著性。
乳腺钼靶密度与乳腺DCIS和浸润性乳腺癌的关联强度相似,支持这两种疾病可能具有共同病因的假说。